Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-44.74	31.52	61.1	110.2
Depreciation & Amortization	68.36	63.45	57.07	43.74
Other Amortization	0.28	-	-	-
Loss (Gain) From Sale of Assets	-0.04	-0	-0.14	0.6
Asset Writedown & Restructuring Costs	28.46	0.4	0.24	-
Loss (Gain) From Sale of Investments	-2.67	-5.79	-3.31	-12.08
Provision & Write-off of Bad Debts	8.45	3.12	8.5	1.65
Other Operating Activities	-3.93	-1.68	-0.11	-5.82
Change in Accounts Receivable	5.03	-52.18	-78.96	-27.68
Change in Inventory	16.68	3.58	-11.9	-32.27
Change in Accounts Payable	21.42	-33.15	-17.88	5.25
Change in Other Net Operating Assets	-	-6.81	-6.14	5.07
Operating Cash Flow	89.36	3.53	9.09	90.12
Operating Cash Flow Growth	2434.71%	-61.21%	-89.92%	-19.34%
Capital Expenditures	-84.91	-129.63	-93.12	-188.16
Sale of Property, Plant & Equipment	-	-	0.86	0.5
Investment in Securities	78.94	141.45	119.3	49.4
Other Investing Activities	2.29	10.05	8.98	11.06
Investing Cash Flow	-3.68	21.86	36.01	-127.21
Long-Term Debt Issued	14	-	-	-
Total Debt Issued	14	-	-	-
Long-Term Debt Repaid	-0.78	-0.37	-0.12	-0.14
Net Debt Issued (Repaid)	13.22	-0.37	-0.12	-0.14
Issuance of Common Stock	-	-	-	8.14
Common Dividends Paid	-14.35	-32.77	-36.81	-40.81
Other Financing Activities	-18.23	0.05	0.24	0.51
Financing Cash Flow	-19.36	-33.09	-36.7	-32.3
Foreign Exchange Rate Adjustments	0	0	0	-0
Net Cash Flow	66.33	-7.71	8.4	-69.39
Free Cash Flow	4.45	-126.11	-84.04	-98.04
Free Cash Flow Margin	1.47%	-41.83%	-25.57%	-27.35%
Free Cash Flow Per Share	0.01	-0.32	-0.21	-0.24
Cash Income Tax Paid	15.06	30.93	24.25	28.43
Levered Free Cash Flow	18.35	-113.08	-92.62	-126.34
Unlevered Free Cash Flow	18.36	-113.08	-92.62	-126.34
Change in Working Capital	35.19	-87.5	-114.26	-48.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.